Stock Price
192.92
Daily Change
-2.48 -1.27%
Monthly
-30.08%
Yearly
-27.75%
Q1 Forecast
194.59

Cochlear reported AUD2.65M in Interest Expense on Debt for its fiscal semester ending in June of 2025.





Interest Expense On Debt Change Date
Ansell USD 20.9M 1.1M Jun/2025
Avita Medical AUD 1.25M 100K Jun/2025
Cochlear AUD 2.65M 3.05M Jun/2025
CSL USD 104M 136M Jun/2025
Fisher Paykel Healthcare NZD 5.5M 700K Dec/2025
Healius AUD 32.8M 15.4M Dec/2024
Integral Diagnostics AUD 5.34M 6.08M Jun/2024
Mayne Pharma AUD 1.2M 50K Jun/2024
Mesoblast USD 10.46M 260K Jun/2024
Monash IVF AUD 3.84M 2.43M Jun/2025
Nanosonics AUD 779K 94K Jun/2025
Polynovo AUD 506K 130K Jun/2025
Ramsay Health Care AUD 316.1M 10.4M Jun/2025
Regis Healthcare AUD 31.07M 30.94M Jun/2025
ResMed USD 775K 886K Dec/2024
Sigma Healthcare AUD 7.97M 365K Jan/2024
Somnomed AUD 2.12M 1.62M Jun/2023
Sonic Healthcare AUD 86.91M 43.94M Dec/2024
Telix Pharmaceuticals AUD 7.62M 11.22M Dec/2025